Identification of functional endothelial protein C receptor in human plasma

Journal of Clinical Investigation

Volumn 100, Issue 2, 1997, Pages 411-418

  Kurosawa, Shinichiro ^a   Stearns Kurosawa, Deborah J ^a   Hidari, Noriko ^a   Esmon, Charles T ^a,b,c,d  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d NONE   (United States)

Author keywords

Activated protein C; Anticoagulation; Endothelial cells; Protein C; Soluble protein C receptor

Indexed keywords

ACTIVATED PROTEIN C; CELL RECEPTOR;

ANTICOAGULATION; ARTICLE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING;

EID: 0030742589     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119548     Document Type: Article

References (50)

1. Esmon, C.T., and H.P. Schwarz. 1995. An update on clinical and basic aspects of the protein C anticoagulant pathway. Trends Cardiovasc. Med. 5:141-158.
2. Reitsma, P.H., F. Bernardi, R.G. Doig, S. Gandrille, J.S. Greengard, H. Ireland, M. Krawczak, B. Lind, G.L. Long, S.R. Poort, et al. 1995. Protein C deficiency: a database of mutations, 1995 update. Thromb. Haemostasis. 73:876-879.
3. Rivard, G.E., M. David, C. Farrell, and H.P. Schwarz. 1995. Treatment of purpura fulminans in meningococcemia with protein C concentrate. J. Pediatr. 126:646-652.
4. Gerson, W.T., J.D. Dickerman, E.G. Bovill, and E. Golden. 1993. Severe acquired protein C deficiency in purpura fulminans associated with disseminated intravascular coagulation: treatment with protein C concentrate. Pediatrics. 91:418-422.
5. Taylor, F.B., Jr., A. Chang, C.T. Esmon, A. D'Angelo, S. Vigano-D'Angelo, and K.E. Blick. 1987. Protein C prevents the coagulopathic and lethal effects of E. coli infusion in the baboon. J. Clin. Invest. 79:918-925.
6. Hancock, W.W., A. Tsuchida, H. Hau, N.M. Thomson, and H.H. Salem. 1992. The anticoagulants protein C and protein S display potent anti-inflammatory and immunosuppressive effects relevant to transplant biology and therapy. Transplant. Proc. 24:2302-2303.
7. Fukudome, K., and C.T. Esmon. 1994. Identification, cloning and regulation of a novel endothelial cell protein C/activated protein C receptor. J. Biol. Chem. 269:26486-26491.
8. Stearns-Kurosawa, D.J., S. Kurosawa, J.S. Mollica, G.L. Ferrell, and C.T. Esmon. 1996. The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. Proc. Natl. Acad. Sci. USA. 93:10212-10216.
9. Esmon, C.T., and W.G. Owen. 1981. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc. Natl. Acad. Sci. USA. 78:2249-2252.
10. Dittman, W.A. 1991. Thrombomodulin: biology and potential cardiovascular applications. Trends Cardiovasc. Med. 1:331-336.
11. Fukudome, K., S. Kurosawa, D.J. Stearns-Kurosawa, X. He, A.R. Rezaie, and C.T. Esmon. 1996. The endothelial cell protein C receptor: cell surface expression and direct ligand binding by the soluble receptor. J. Biol. Chem. 271:17491-17498.
12. Regan, L.M., D.J. Stearns-Kurosawa, S. Kurosawa, J. Mollica, K. Fukudome, and C.T. Esmon. 1996. The endothelial cell protein C receptor: inhibition of activated protein C anticoagulant function without modulation of reaction with proteinase inhibitors. J. Biol. Chem. 271:17499-17503.
13. Jackman, R.W., D.L. Beeler, L. Fritze, G. Soff, and R.D. Rosenberg. 1987. Human thrombomodulin gene is intron depleted: nucleic acid sequences of the cDNA and gene predict protein structure and suggest sites of regulatory control. Proc. Natl. Acad. Sci. USA. 84:6425-6429.
14. Wen, D., W.A. Dittman, R.D. Ye, L.L. Deaven, P.W. Majerus, and J.E. Sadler. 1987. Human thrombomodulin: complete cDNA sequence and chromosome localization of the gene. Biochemistry. 26:4350-4357.
15. Suzuki, K., H. Kusumoto, Y. Deyashiki, J. Nishioka, I. Maruyama, M. Zushi, S. Kawahara, G. Honda, S. Yamamoto, and S. Horiguchi. 1987. Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation. EMBO (Eur. Mol. Biol. Organ.) J. 6:1891-1897.
16. Galvin, J.B., S. Kurosawa, K. Moore, C.T. Esmon, and N.L. Esmon. 1987. Reconstitution of rabbit thrombomodulin into phospholipid vesicles. J. Biol. Chem. 262:2199-2205.
17. Parkinson, J.F., B.W. Grinnell, R.E. Moore, J. Hoskins, C.J. Vlahos, and N.U. Bang. 1990. Stable expression of a secretable deletion mutant of recombinant human thrombomodulin in mammalian cells. J. Biol. Chem. 265:12602-12610.
18. Ye, J., N.L. Esmon, C.T. Esmon, and A.E. Johnson. 1991. The active site of thrombin is altered upon binding to thrombomodulin: two distinct structural changes are detected by fluorescence, but only one correlates with protein C activation. J. Biol. Chem. 266:23016-23021.
19. Lu, R., N.L. Esmon, C.T. Esmon, and A.E. Johnson. 1989. The active site of the thrombin-thrombomodulin complex: a fluorescence energy transfer measurement of its distance above the membrane surface. J. Biol. Chem. 264: 12956-12962.
20. Ye, J., L. Liu, C.T. Esmon, and A.E. Johnson. 1992. The fifth and sixth growth factor-like domains of thrombomodulin bind to the anion exosite of thrombin and alter its specificity. J. Biol. Chem. 267:11023-11028.
21. Hofsteenge, J., H. Taguchi, and S.R. Stone. 1986. Effect of thrombomodulin on the kinetics of the interaction of thrombin with substrates and inhibitors. Biochem. J. 237:243-251.
22. Mathews, I.I., K.P. Padmanabhan, and A. Tulinsky. 1994. Structure of a nonadecapeptide of the fifth EGF domain of thrombomodulin complexed with thrombin. Biochemistry. 33:13547-13552.
23. Esmon, C.T., N.L. Esmon, and K.W. Harris. 1982. Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation. J. Biol. Chem. 257:7944-7947.
24. Sadler, J.E., S.R. Lentz, J.P. Sheehan, M. Tsiang, and Q. Wu. 1993. Structure-function relationships of the thrombin-thrombomodulin interaction. Haemostasis. 23:183-193.
25. Bourin, M.C., and U. Lindahl. 1993. Glycosaminoglycans and the regulation of blood coagulation. Biochem. J. 289:313-330.
26. Rezaie, A.R., S.T. Cooper, F.C. Church, and C.T. Esmon. 1995. Protein C inhibitor is a potent inhibitor of the thrombin-thrombomodulin complex. J. Biol. Chem. 270:25336-25339.
27. Takano, S., S. Kimura, S. Ohdama, and N. Aoki. 1990. Plasma thrombomodulin in health and diseases. Blood. 76:2024-2029.
28. Ishii, H., and P.W. Majerus. 1985. Thrombomodulin is present in human plasma and urine. J. Clin. Invest. 76:2178-2181.
29. Tanaka, A., H. Ishii, S. Hiraishi, M. Kazama, and H. Maezawa. 1991. Increased thrombomodulin values in plasma of diabetic men with microangiopathy. Clin. Chem. 27:269-272.
30. Takahashi, H., M. Hanano, K. Wada, W. Tatewaki, H. Niwano, J. Tsubouchi, M. Nakano, T. Nakamura, and A. Shibata. 1991. Circulating thrombomodulin in thrombotic thrombocytopenic purpura. Am. J. Hematol. 38:174-177.
31. Asakura, H., H. Jokaji, M. Saito, C. Uotani, I. Kumabashiri, E. Morishita, M. Yamazaki, and T. Matsuda. 1991. Plasma levels of soluble thrombomodulin increase in cases of disseminated intravascular coagulation with organ failure. Am. J. Hematol. 38:281-287.
32. Wada, H., M. Ohiwa, T. Kaneko, S. Tamaki, M. Tanigawa, S. Shirakawa, M. Koyama, T. Hayashi, and K. Suzuki. 1992. Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation. Am. J. Hematol. 39:20-24.
33. Takahashi, H., S. Ito, M. Hanano, K. Wada, H. Niwano, Y. Seki, and A. Shibata. 1992. Circulating thrombomodulin as a novel endothelial cell marker: comparison of its behavior with von Willebrand factor and tissue-type plasminogen activator. Am. J. Hematol. 41:32-39.
34. Ohdama, S., O. Matsubara, and N. Aoki. 1994. Plasma thrombomodulin in Wegener's granulomatosis as an indicator of vascular injuries. Chest. 106: 666-671.
35. Mather, T., V. Oganessyan, P. Hof, R. Huber, S. Foundling, C. Esmon, and W. Bode. 1996. The 2.8 Å crystal structure of Gla-domainless activated protein C. EMBO (Eur. Mol. Biol. Organ.) J. 15:6822-6831.
36. Esmon, C.T., N.L. Esmon, B.F. Le Bonniec, and A.E. Johnson. 1993. Protein C activation. Methods Enzymol. 222:359-385.
37. Owen, W.G., C.T. Esmon, and C.M. Jackson. 1974. The conversion of prothrombin to thrombin. I. Characterization of the reaction products formed during the activation of bovine prothrombin. J. Biol. Chem. 249:594-605.
38. Esmon, C.T. 1977. Factors regulating the inhibition of thrombin by antithrombin III. In Chemistry and Biology of Thrombin. R.L. Lundblad, J.W. Fenton II, and K.G. Mann, editors. Ann Arbor Science Publishers, Inc., Ann Arbor, MI. 403-411.
39. 2+ binding to both antigen and antibody. J. Biol. Chem. 263:826-832.
40. Edgell, C.S., C.C. McDonald, and J.B. Graham. 1983. Permanent cell line expressing human factor VIII-rclated antigen established by hybridization. Proc. Natl. Acad. Sci. USA. 80:3734-3737.
41. 2Cl. Biochemistry. 27:6633-6639.
42. 4. Nature (Lond.). 227:680-685.
43. Quehenberger, P., U. Loner, S. Kapiotis, S. Handler, B. Sehneider, J. Huber, and W. Speiser. 1996. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives. Thromb. Haemostasis. 76:729-734.
44. 43a. Laszik, Z., A. Mitro, F.B. Taylor, Jr., G. Ferrell, and C.T. Esmon. 1997. The human protein C receptor is present primarily on endothelium of large blood vessels: implications for the control of the protein C pathway. Circulation. In press.
45. Heaney, M.L., and D.W. Golde. 1996. Soluble cytokine receptors. Blood. 87:847-857.
46. Arend, W.P., M. Malyak, M. Smith, Jr., T.D. Whisenand, J.L. Slack, J.E. Sims, J.G. Giri, and S.K. Dower. 1994. Binding of IL-1α, IL-1β, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. J. Immunol. 153:4766-4774.
47. Fukudome, K., and C.T. Esmon. 1995. Molecular cloning and expression of murine and bovine endothelial cell protein C/activated protein C receptor (EPCR). The structural and functional conservation in human, bovine, and murine EPCR. J. Biol. Chem. 270:5571-5577.
48. Mullberg, J., W. Oberthur, F. Lottspeich, E. Mehl, E. Dittrich, L. Graeve, P.C. Heinrich, and S. Rose-John. 1994. The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site. J. Immunol. 152:4958-4968.
49. Lust, J.A., K.A. Donovan, M.P. Kline, P.R. Greipp, R.A. Kyle, and N.J. Maihle. 1992. Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine. 4:96-100.
50. Horiuchi, S., Y. Koyanagi, Y. Zhou, H. Miyamoto, Y. Tanaka, M. Waki, A. Matsumoto, M. Yamamoto, and N. Yamamoto. 1994. Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism. Eur. J. Immunol. 24:1945-1948.